Kiersten Archer is a Director within Controls Risks’ Compliance, Forensics and Intelligence practice in the Americas region. She has significant experience in corporate compliance, fraud and anti-corruption matters.

Kiersten specializes in bribery and fraud investigations, compliance risk assessments and development of best-practice anti-corruption compliance programs. Her experience in matters involving violations of the US Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act includes global financial and forensic accounting investigations with suspected violations by US corporations or their international operating divisions, agents or distributors. She has also worked on global risk assessments, SEC and DOJ enforcement-driven investigations, and monitorships in numerous global jurisdictions.

Kiersten’s recent experience includes:

• Participation in global on-site anti-corruption investigations and risk assessments for medical devices, pharmaceutical and dental implant companies, including focused transactional testing and data analytics to determine FCPA corruption risk.
• Assisted clients with global compliance program gap analyses and remediation, including development of corruption risk profiles.
• In a large financial institution securities litigation matter, assisted in responding to allegations that senior management issued materially false and misleading financial reports, artificially inflating the price of the entity’s securities.
• Participated in a complex independent investigation into a leading pharmaceutical company’s operations and interactions with healthcare professionals, distributors and vendors in China.Played a key role on a court-appointed independent compliance consulting team for a large global pharmaceutical company in connection with an FCPA settlement with the SEC.

Prior to joining Control Risks, Kiersten spent a decade at FTI Consulting where she was a senior director in its forensic and litigation consulting practice focusing on anti-corruption compliance and investigations.